Cantor Fitzgerald, L. P. Biomea Fusion, Inc. Transaction History
Cantor Fitzgerald, L. P.
- $656 Million
- Q1 2024
A detailed history of Cantor Fitzgerald, L. P. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 21,000 shares of BMEA stock, worth $91,349. This represents 0.05% of its overall portfolio holdings.
Number of Shares
21,000Holding current value
$91,349% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
120Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
State Street Corp Boston, MA4.49MShares$19.5 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$15.5 Million3.07% of portfolio
-
Laurion Capital Management LP New York, NY2.72MShares$11.8 Million0.36% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$9.17 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.58 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $127M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...